Dulaglutide Dulaglutide (Trulicity) is also a GLP-1 agonist, and it has a similar mechanism of action to liraglutide
Remarkably, one in three individuals achieved a 25% reduction in body weight, equating to a loss of 58 pounds Semaglutide (Wegovy): Wegovy users have experienced significant weight loss as well, with adults averaging a 15% reduction in body weight and a 16.1% decrease in BMI among children aged 12 and older Clinical trial comparisons: SURMOUNT-1 (Zepbound): Participants using the highest dose of Zepbound (15 mg) experienced an average weight loss of 21% after 72 weeks SURMOUNT-2 (Zepbound): In adults with type 2 diabetes, the same high dose led to a 12% weight loss after 72 weeks Wegovy trials: Comparable trials for Wegovy have shown an average weight loss of 15% from the starting weight in adults who are overweight or have obesity Cost considerations: The price of these medications is a factor to consider
2 (4), 2631 (2020) Gopinath, H., Karthikeyan, K.: Turmeric: a condiment, cosmetic and cure
Tranexamic Acid A great treatment for random dark spots and rosacea, tranexamic acid is powerful and generally safe
Phase 2 weight loss (48 weeks): 22.8% at 8 mg maintenance 12 mg Weeks 13+ Maximum trial dose
Selling them labeled "for research use only" is currently permitted